In addition, most women cute-n-tiny.com usa cialis experience an improvement in their erectile dysfunction. Over cheap viagra on line 30 percent of men around the world are impotent. The company produce these drugs do not expense money on advertisements they expense money on researches of sildenafil Citrate drug: Sildenafil citrate or viagra 100 mg cute-n-tiny.com is medication belongs to PDE-5 inhibitor family. These products are available either in tablets/pills or a jelly liquid version for easy sildenafil buy consumption.
Takeda is also working with U.S. biotech Novavax to help scale production of their COVID-19 shot. (Takeda)
Japanese drugmaker Takeda has quickly emerged as one of the leading forces in the fight against COVID-19 as a vaccine manufacturing partner and R&D lead on a convalescent plasma-based therapy. Now, Takeda will help another biotech distribute its potential COVID-19 vaccine in the drugmaker’s home country.
Massachusetts biotech Moderna has tapped Takeda to bring 50 million doses of its mRNA-based COVID-19 shots to Japanese shores as part of a government-backed vaccine distribution effort, the partners said Thursday.
Takeda will import and distribute Moderna’s shot, dubbed mRNA-1273, starting in the first half of next year, as well as handle local regulatory approvals, the drugmaker said. Moderna’s vaccine is currently working through a pivotal, 30,000-patient phase 3 study, with early data expected sometime in late November or after.
Financial terms of the deal were not disclosed. A Moderna spokeswoman could not be reached for comment by press time.
The newest partnership with Moderna adds to Takeda’s growing role in the fight against COVID-19.
